%0 Editorial
%T The Biden Administration's Push to Lower Drug Prices Through March-In Rights.
%A Aaron DG
%A Anderson JJ
%J JAMA
%V 332
%N 6
%D 2024 08 13
%M 39008321
%F 157.335
%R 10.1001/jama.2024.12327
%X This Viewpoint explores a 2023 Biden administration proposal for US agencies to use their march-in rights and the impact this proposed framework could have on drug prices.